{"id":"W2314709150","doi":"10.1097/00054725-201212001-00059","title":"Vedolizumab Induction Therapy for Patients With Crohn’s Disease and Prior Anti-TNF Antagonist Failure: A Randomized, Placebo-controlled, Double-blind, Multicenter Trial","year":2012,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Vedolizumab; Clinical endpoint; Placebo; Internal medicine; Population; Antagonist; Gastroenterology; Randomization; Crohn's disease; Clinical trial; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001834109,0.001377628,0.003246172,0.0003711308,0.0005276177,0.001143502,0.0008398752,0.002052107,0.003446137],"category_scores_gemma":[0.001592252,0.0006448384,0.001538234,0.0004369925,0.001154026,0.0009747958,0.0003751125,0.002907627,0.000767676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005164625,"about_ca_system_score_gemma":0.001107998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006103474,"about_ca_topic_score_gemma":0.001434495,"domain_scores_codex":[0.9993566,0.0003122699,0.0000508156,0.0001165788,0.00005166552,0.0001120228],"domain_scores_gemma":[0.9989766,0.0002512251,0.0002271084,0.00007538613,0.00007580044,0.0003939059],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9802532,0.00522468,0.0006136267,0.00039639,0.0004323757,0.00002966131,0.0000374497,0.0001285909,0.00259085,0.00005894914,0.0003860335,0.009848258],"study_design_scores_gemma":[0.9472708,0.05008123,0.001529825,0.00002449909,0.0002129157,0.00002199025,0.000009276557,0.0001942821,0.0002379259,0.00004777569,0.0003622831,0.000007318246],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841495,0.007677717,0.0007683668,0.0006873815,0.0005449165,0.003733736,0.0007503801,0.0001131872,0.001574752],"genre_scores_gemma":[0.9830534,0.004542154,0.001743316,0.001405043,0.0007487541,0.005338734,0.001039173,0.00002249681,0.002106937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003446137,"threshold_uncertainty_score":0.01152843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009801132830696786,"score_gpt":0.2480498987808304,"score_spread":0.2382487659501336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}